News / Events :: BioXcel Therapeutics, Inc. (BTAI)

Recent News View All News

BioXcel Therapeutics Receives FDA Clearance of IND for Phase 2 Trial with BXCL501 for the Treatment of Agitation Associated with Delirium

October 26, 2020

BioXcel Therapeutics to Present at the H.C. Wainwright 22nd Annual Global Investment Conference

September 9, 2020

Recent Events View IR Calendar

H.C. Wainwright 22nd Annual Global Investment Conference

Sep 16, 2020 • 9:30am EDT

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings